Developing a reliable immune cell-based assay requires significant scientific knowledge and optimization time investment. Immune cell-based screens also require precise and consistent handling for repeatable results to reduce variations in assay performance and unreliable data.
Partner with Horizon for a robust data set for your assay. Avoid the frustration of not having sufficient resources and leverage our immune cell expertise and instrumentation to support the future of your project.

Standardized immune cell assays - ImmuSignature™

Rapidly evaluate therapeutic efficacy in relevant immune cell-based environments with optimized compound screening assays
  • Mixed Lymphocyte Reaction
  • T Cell Activation
  • Complement-Dependent Cytotoxicity

CRISPR immune cell screens

Answer clinically relevant biological questions with gene editing and screening services in primary human immune cells.
  • Pooled and arrayed T cell screening
  • Arrayed B cell screening
  • Synthetic and lentiviral workflow options

Webinar: Gene modulation in primary immune cells

Can base editing move cancer cell therapy towards off-the-shelf treatments?

Learn about the roles autologous and allogeneic treatments will play in the future of cell-based immunotherapy.

CRISPR editing in T cells

Learn tips and considerations for successful CRISPR gene editing in primary human T cells.

CRISPR editing in monocytes

Learn about the importance of monocytes for future gene editing applications.

Immunology services brochure

View Horizon's full range of industry leading immunology services including target identification and compound screening assays